Search Results 861-870 of 25599 for treatment resistant depression

  1. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma. Print ...

  2. Erectile dysfunction - Care at Mayo Clinic

    Mayo offers many options for these men, including intraurethral therapy, penile injection therapies, vacuum erection devices and surgery. Efficient care. Close ...

  3. Publications - Matthew M. Clark, Ph.D., L.P. - Mayo Clinic

    Barriers to accepting mental health care in cancer patients with depression. Soc Work Health Care. 2020 Jul; 59 (6):351-364 Epub 2020 June 14. View PubMed ...

  4. HEAL-IST IDE Trial - Mayo Clinic

    The ideal treatment of inappropriate sinus ... drug resistant IST and POTS. Importantly, in our ... depression who was steadily treated with ...

  5. Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Clinical Trials · Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma · More about research at Mayo Clinic.

  6. A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Participation eligibility · Relapsed or refractory Hodgkin lymphoma following failure of standard frontline chemotherapy for the treatment of classical Hodgkin ...

  7. Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma - Mayo Clinic

    Participation eligibility · Diagnosis of CD30+ classical Hodgkin lymphoma reconfirmed by histopathology. · Relapsed or refractory disease after standard therapy ...

  8. Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma - Mayo Clinic

    Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom ...

  9. 177Lu-DTPA-Omburtamab Radioimmunotherapy toTreat Recurrent or Refractory Medulloblastoma - Mayo Clinic

    177Lu-DTPA-Omburtamab Radioimmunotherapy toTreat Recurrent or Refractory Medulloblastoma · Overview · Participation eligibility · More information · Additional ...

  10. Publications - Cassandra N. Moore, M.D. - Mayo Clinic

    The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. Prostate. 2022 Sep; 82 ...